Artia Global Partners LP
Filing Date
Global Rank
#2,313
/ 8,232
▼ 158
Top Industry
Biotechnology
82.7%
3Y Alpha vs SPY
-14.2%
Period ended 2 months ago
Filed May 15, 2026 · 29d
14 quarters · since Dec 2022
Clone Performance
Jun 2023–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+22.5%
SPY
+76.5%
Annualised alpha
-13.8%
Max drawdown
−39.5%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
49 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
29.7%
−0.6 pts
Top 5
59.3%
−5.5 pts
Top 10
73.7%
−8.1 pts
HHI
1,226
Diversified−107
Portfolio Trend
14 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $499,419,986 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
6 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| XENE | Xenon Pharmaceuticals Inc. | +25,000 | 65,000 | $3,779,750 | |
| RVMD | Revolution Medicines, Inc. | +20,800 | 124,990 | $12,155,277 | |
| BTSG | BrightSpring Health Services, Inc. | +12,200 | 53,800 | $2,292,418 | |
| BLTE | Belite Bio, Inc | +7,000 | 24,989 | $3,984,246 | |
| DRUG | Bright Minds Biosciences Inc. | +5,000 | 38,407 | $2,802,558 | |
| CELC | Celcuity Inc. | +2,676 | 15,576 | $1,777,844 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
11 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| VKTX | Viking Therapeutics, Inc. | −538,634 | 180,731 | $5,880,986 | |
| SLNO | Soleno Therapeutics Inc | −515,208 | 68,490 | $2,293,045 | |
| INSM | INSMED Inc | −193,800 | 908,412 | $148,543,530 | |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | −42,100 | 162,990 | $13,678,120 | |
| ARGX | Argenx SE | −34,960 | 29,739 | $21,716,904 | |
| PROK | Prokidney Corp. | −31,472 | 1,806,939 | $3,234,420 | |
| AVTX | Avalo Therapeutics, Inc. | −12,600 | 28,970 | $432,522 | |
| LLY | ELI LILLY & Co | −12,280 | 38,220 | $35,153,609 | |
| ABVX | Abivax S.A. | −9,900 | 600,747 | $66,893,178 | |
| NUVL | Nuvalent, Inc. | −3,200 | 4,900 | $502,005 | |
| PTGX | Protagonist Therapeutics, Inc | −20 | 22,931 | $2,416,927 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
11 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| AZN | Astrazeneca PLC | 95,376 | $18,810,054 | |
| MRNA | Moderna, Inc. | 200,000 | $10,160,000 | |
| ALMS | Alumis Inc. | 325,046 | $7,160,763 | |
| MRK | Merck & Co., Inc. | 46,700 | $5,617,543 | |
| TERN | Terns Pharmaceuticals, Inc. | 104,800 | $5,525,056 | |
| JNJ | Johnson & Johnson | 22,600 | $5,524,344 | |
| BIIB | Biogen Inc. | 18,437 | $3,380,055 | |
| EWTX | Edgewise Therapeutics, Inc. | 65,500 | $2,063,250 | |
| CYTK | Cytokinetics Inc | 16,300 | $1,074,333 | |
| ELVN | Enliven Therapeutics, Inc. | 20,900 | $819,280 | |
| APGE | Apogee Therapeutics, Inc. | 5,886 | $495,424 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
7 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| QURE | uniQure N.V. | 1,023,539 | $24,493,288 | |
| ALNY | Alnylam Pharmaceuticals, Inc. | 17,400 | $6,919,110 | |
| PVLA | Palvella Therapeutics, Inc. | 59,200 | $6,196,464 | |
| OCUL | Ocular Therapeutix, Inc | 226,261 | $2,746,808 | |
| UPB | Upstream Bio, Inc. | 68,653 | $1,863,928 | |
| ANRO | Alto Neuroscience, Inc. | 29,192 | $519,617 | |
| LYRA | Lyra Therapeutics, Inc. | 8,756 | $26,968 | |
| No positions match the current search. | ||||
49 positions ·
$499,419,986 total
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| INSM |
INSMED Inc
Healthcare
|
Reduced | 908,412 | $148,543,530 | 29.74% | |
| ABVX |
Abivax S.A.
Healthcare
|
Reduced | 600,747 | $66,893,178 | 13.39% | |
| LLY |
ELI LILLY & Co
Healthcare
|
Reduced | 38,220 | $35,153,609 | 7.04% | |
| TRVI |
Trevi Therapeutics, Inc.
Healthcare
|
Held | 2,013,602 | $24,022,271 | 4.81% | |
| ARGX |
Argenx SE
Healthcare
|
Reduced | 29,739 | $21,716,904 | 4.35% | |
| AZN |
Astrazeneca PLC
Healthcare
|
NEW | 95,376 | $18,810,054 | 3.77% | |
| NAMS |
NewAmsterdam Pharma Co N.V.
Healthcare
|
Held | 503,936 | $16,130,991 | 3.23% | |
| DNTH |
Dianthus Therapeutics, Inc. /DE/
Healthcare
|
Reduced | 162,990 | $13,678,120 | 2.74% | |
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
Added | 124,990 | $12,155,277 | 2.43% | |
| IONS |
Ionis Pharmaceuticals Inc
Healthcare
|
Held | 144,376 | $10,841,193 | 2.17% | |
| MRNA |
Moderna, Inc.
Healthcare
|
NEW | 200,000 | $10,160,000 | 2.03% | |
| EYPT |
EyePoint, Inc.
Healthcare
|
Held | 767,098 | $9,887,893 | 1.98% | |
| DGX |
Quest Diagnostics Inc
Healthcare
|
Held | 40,817 | $7,999,315 | 1.60% | |
| ALMS |
Alumis Inc.
Healthcare
|
NEW | 325,046 | $7,160,763 | 1.43% | |
| VKTX |
Viking Therapeutics, Inc.
Healthcare
|
Reduced | 180,731 | $5,880,986 | 1.18% | |
| MRK |
Merck & Co., Inc.
Healthcare
|
NEW | 46,700 | $5,617,543 | 1.12% | |
| TERN |
Terns Pharmaceuticals, Inc.
Healthcare
|
NEW | 104,800 | $5,525,056 | 1.11% | |
| JNJ |
Johnson & Johnson
Healthcare
|
NEW | 22,600 | $5,524,344 | 1.11% | |
| SION |
Sionna Therapeutics, Inc.
Healthcare
|
Held | 119,741 | $4,800,416 | 0.96% | |
| SRRK |
Scholar Rock Holding Corp
Healthcare
|
Held | 96,285 | $4,733,370 | 0.95% | |
| RAPP |
Rapport Therapeutics, Inc.
Healthcare
|
Held | 138,508 | $4,333,915 | 0.87% | |
| ASND |
Ascendis Pharma A/S
Healthcare
|
Held | 17,740 | $4,057,670 | 0.81% | |
| BLTE |
Belite Bio, Inc
Healthcare
|
Added | 24,989 | $3,984,246 | 0.80% | |
| XENE |
Xenon Pharmaceuticals Inc.
Healthcare
|
Added | 65,000 | $3,779,750 | 0.76% | |
| MLYS |
Mineralys Therapeutics, Inc.
Healthcare
|
Held | 137,800 | $3,733,002 | 0.75% | |
| ROIV |
Roivant Sciences Ltd.
Healthcare
|
Held | 129,800 | $3,595,460 | 0.72% | |
| PALI |
Palisade Bio, Inc.
Healthcare
|
Held | 1,992,367 | $3,486,642 | 0.70% | |
| BIIB |
Biogen Inc.
Healthcare
|
NEW | 18,437 | $3,380,055 | 0.68% | |
| PROK |
Prokidney Corp.
Healthcare
|
Reduced | 1,806,939 | $3,234,420 | 0.65% | |
| ABBV |
AbbVie Inc.
Healthcare
|
Held | 14,500 | $3,153,605 | 0.63% | |
| UTHR |
UNITED THERAPEUTICS Corp
Healthcare
|
Held | 5,000 | $2,964,900 | 0.59% | |
| DRUG |
Bright Minds Biosciences Inc.
Healthcare
|
Added | 38,407 | $2,802,558 | 0.56% | |
| PTGX |
Protagonist Therapeutics, Inc
Healthcare
|
Reduced | 22,931 | $2,416,927 | 0.48% | |
| SLNO |
Soleno Therapeutics Inc
Healthcare
|
Reduced | 68,490 | $2,293,045 | 0.46% | |
| BTSG |
BrightSpring Health Services, Inc.
Healthcare
|
Added | 53,800 | $2,292,418 | 0.46% | |
| TVTX |
Travere Therapeutics, Inc.
Healthcare
|
Held | 70,700 | $2,100,497 | 0.42% | |
| EWTX |
Edgewise Therapeutics, Inc.
Healthcare
|
NEW | 65,500 | $2,063,250 | 0.41% | |
| CELC |
Celcuity Inc.
Healthcare
|
Added | 15,576 | $1,777,844 | 0.36% | |
| BBIO |
BridgeBio Pharma, Inc.
Healthcare
|
Held | 20,400 | $1,514,904 | 0.30% | |
| KNSA |
Kiniksa Pharmaceuticals International, plc
Healthcare
|
Held | 29,200 | $1,405,980 | 0.28% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
NEW | 16,300 | $1,074,333 | 0.22% | |
| ELVN |
Enliven Therapeutics, Inc.
Healthcare
|
NEW | 20,900 | $819,280 | 0.16% | |
| PRAX |
Praxis Precision Medicines, Inc.
Healthcare
|
Held | 2,500 | $805,475 | 0.16% | |
| TENX |
Tenax Therapeutics, Inc.
Healthcare
|
Held | 42,080 | $672,859 | 0.13% | |
| KOD |
Kodiak Sciences Inc.
Healthcare
|
Held | 17,019 | $648,764 | 0.13% | |
| NUVL |
Nuvalent, Inc.
Healthcare
|
Reduced | 4,900 | $502,005 | 0.10% | |
| APGE |
Apogee Therapeutics, Inc.
Healthcare
|
NEW | 5,886 | $495,424 | 0.10% | |
| AVTX |
Avalo Therapeutics, Inc.
Healthcare
|
Reduced | 28,970 | $432,522 | 0.09% | |
| PEPG |
PepGen Inc.
Healthcare
|
Held | 205,324 | $363,423 | 0.07% |